Search Results - "Vinge, Lotte"

Exercise in myasthenia gravis: A feasibility study of aerobic and resistance training by Rahbek, Martin Amadeus, Mikkelsen, Erik Elgaard, Overgaard, Kristian, Vinge, Lotte, Andersen, Henning, Dalgas, Ulrik

“…ABSTRACT Introduction: It has not been established whether progressive resistance training (PRT) and aerobic training (AT) are feasible and efficient in…”
Get full text

Oral function in patients with myasthenia gravis by Donskov, Agnete Overgaard, Shimada, Akiko, Vinge, Lotte, Svensson, Peter, Andersen, Henning

“…Myasthenia Gravis (MG) is characterised by muscle weakness and increased fatigability. The aim of this pilot study was to investigate if patients with MG…”
Get full text

Muscle strength and fatigue in newly diagnosed patients with myasthenia gravis by Vinge, Lotte, Andersen, Henning

“…ABSTRACT Introduction: Dynamometry is increasingly used as an objective measurement of muscle strength in neurological diseases. No study has applied…”
Get full text

Muscle weakness and functional disability in patients with myasthenia gravis by Vinge, Lotte, Jakobsen, Johannes, Andersen, Henning

“…ABSTRACT Introduction: Muscle weakness and functional disability have not been evaluated in a population‐based study of patients with myasthenia gravis (MG)…”
Get full text

Muscle strength and fatigue in newly diagnosed patients with myasthenia gravis: Strength and Fatigue in MG by Vinge, Lotte, Andersen, Henning

Get full text

Gender differences in clinical outcomes in myasthenia gravis: Aprospective cohort study by Thomsen, Jan L S, Vinge, Lotte, Harbo, Thomas, Andersen, Henning

“…Introduction/AimsIt is uncertain whether clinical outcomes differ between male and female patients with myasthenia gravis (MG) while receiving standard…”
Get full text

A population-based follow-up study of maximal muscle strength and mobility in patients with myasthenia gravis by Thomsen, Jan Lykke Scheel, Vinge, Lotte, Harbo, Thomas, Andersen, Henning

“…•Residual muscle weakness in a general MG population can improve.•Longer disease duration and greater baseline impairment do not result in less improvement.•MG…”
Get full text

Overactive bladder in patients with myasthenia gravis—A cross‐sectional population‐based study by Donskov, Agnete Overgaard, Vinge, Lotte, Axelsen, Susanne Maigaard, Andersen, Henning

“…Background In myasthenia gravis (MG), first‐line treatment for MG is acetylcholinesterase inhibitors which alleviates symptoms, but concomitantly may cause…”
Get full text

Gender differences in clinical outcomes in myasthenia gravis: A prospective cohort study by Thomsen, Jan L. S., Vinge, Lotte, Harbo, Thomas, Andersen, Henning

“…Introduction/Aims It is uncertain whether clinical outcomes differ between male and female patients with myasthenia gravis (MG) while receiving standard…”
Get full text

Diurnal and day-to-day variation of isometric muscle strength in myasthenia gravis by Vinge, Lotte, Jakobsen, Johannes, Pedersen, Asger Roer, Andersen, Henning

“…ABSTRACT Introduction: In patients with myasthenia gravis (MG), muscle strength is expected to decrease gradually during the day due to physical activities…”
Get full text

Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies by Preisler, Nicolai, Lukacs, Zoltan, Vinge, Lotte, Madsen, Karen Lindhardt, Husu, Edith, Hansen, Regitze Sølling, Duno, Morten, Andersen, Henning, Laub, Michael, Vissing, John

“…Late-onset Pompe disease is a rare, but potentially treatable metabolic myopathy, and therefore should not be overlooked. However, it is not unusual that…”
Get full text

The effect of progressive glomerular disease on megalin-mediated endocytosis in the kidney by Vinge, Lotte, Lees, George E., Nielsen, Rikke, Kashtan, Clifford E., Bahr, Anne, Christensen, Erik I.

“…Background. A well-characterized dog model of the X-linked collagen disease Alport syndrome (XLAS) was used to study the effect of progressive glomerular…”
Get full text